{"id":3617,"date":"2026-09-07T16:16:46","date_gmt":"2026-09-07T14:16:46","guid":{"rendered":"https:\/\/www.amyloidosisalliance.org\/klinische-studies\/"},"modified":"2026-11-03T08:38:44","modified_gmt":"2026-11-03T07:38:44","slug":"klinische-studies","status":"publish","type":"page","link":"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/","title":{"rendered":"Klinische studies"},"content":{"rendered":"\n<nav aria-label=\"Breadcrumb\" class=\"wp-block-group aa-breadcrumb is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"aa-inner\"><a href=\"https:\/\/www.amyloidosisalliance.org\/nl\/\">Home<\/a><span class=\"aa-breadcrumb__sep\">\u203a<\/span><span class=\"aa-breadcrumb__current\">Klinische studies<\/span><\/div>\n<\/nav>\n\n<section class=\"wp-block-group aa-page-hero is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-page-hero__grid is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-overline wp-block-paragraph\">Onderzoek<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Klinische studies<\/h1>\n\n\n\n<p class=\"aa-lead wp-block-paragraph\">Alle studies naar amylo\u00efdose die nu pati\u00ebnten werven, binnenkort starten of op uitnodiging deelnemers opnemen, waar ook ter wereld, rechtstreeks overgenomen van ClinicalTrials.gov en elke dag bijgewerkt.<\/p>\n\n\n\n<p class=\"aa-trial-warn wp-block-paragraph\"><strong>Informatie, geen medisch advies.<\/strong> De Alliantie voert deze studies niet uit en kan u er niet voor inschrijven. Lijkt een studie u relevant, bespreek die dan met de arts die uw amylo\u00efdose behandelt.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-page-hero__photo is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1707\" height=\"1707\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\" alt=\"\" class=\"wp-image-1000\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg 1707w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-1024x1024.jpg 1024w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-150x150.jpg 150w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-768x768.jpg 768w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-1536x1536.jpg 1536w\" sizes=\"auto, (max-width: 1707px) 100vw, 1707px\" \/><\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n<section id=\"trials\" class=\"wp-block-group aa-section aa-section--cream aa-trials-page is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading\">Studies die pati\u00ebnten werven en binnenkort starten<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">De lijst omvat AL-, ATTR- en AA-amylo\u00efdose en cerebrale amylo\u00efde angiopathie. Elke kaart vermeldt hoe het met de studie staat: open voor iedereen die aan de criteria voldoet, nog niet open, of voorbehouden aan mensen die door de onderzoekers worden uitgenodigd. Studies die worden afgesloten, verdwijnen gewoon van de lijst.<\/p>\n\n\n<div class=\"aa-trials aa-no-reveal wp-block-aa-clinical-trials\" data-endpoint=\"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/aa\/v1\/trials\" data-page=\"0\" data-per-page=\"12\"><form class=\"aa-trial-filters\" method=\"get\" action=\"https:\/\/www.amyloidosisalliance.org\/nl\/\"><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_type\">Soort amylo\u00efdose<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_type\" name=\"t_type\"><option value=\"\">Alle soorten<\/option><option value=\"attr\">ATTR (transthyretine)<\/option><option value=\"al\">AL (lichte ketens)<\/option><option value=\"aa\">AA (secundair)<\/option><option value=\"caa\">Cerebrale amylo\u00efde angiopathie<\/option><option value=\"unspecified\">Niet vermeld<\/option><\/select><\/p><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_country\">Land<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_country\" name=\"t_country\"><option value=\"\">Alle landen<\/option><option value=\"Argentina\">Argentina<\/option><option value=\"Australia\">Australia<\/option><option value=\"Austria\">Austria<\/option><option value=\"Belgium\">Belgium<\/option><option value=\"Brazil\">Brazil<\/option><option value=\"Bulgaria\">Bulgaria<\/option><option value=\"Canada\">Canada<\/option><option value=\"Chile\">Chile<\/option><option value=\"China\">China<\/option><option value=\"Croatia\">Croatia<\/option><option value=\"Cyprus\">Cyprus<\/option><option value=\"Czechia\">Czechia<\/option><option value=\"Denmark\">Denmark<\/option><option value=\"Estonia\">Estonia<\/option><option value=\"Finland\">Finland<\/option><option value=\"France\">France<\/option><option value=\"Germany\">Germany<\/option><option value=\"Greece\">Greece<\/option><option value=\"Hong Kong\">Hong Kong<\/option><option value=\"Hungary\">Hungary<\/option><option value=\"Ireland\">Ireland<\/option><option value=\"Israel\">Israel<\/option><option value=\"Italy\">Italy<\/option><option value=\"Japan\">Japan<\/option><option value=\"Latvia\">Latvia<\/option><option value=\"Lithuania\">Lithuania<\/option><option value=\"Malaysia\">Malaysia<\/option><option value=\"Martinique\">Martinique<\/option><option value=\"Mexico\">Mexico<\/option><option value=\"Netherlands\">Netherlands<\/option><option value=\"New Zealand\">New Zealand<\/option><option value=\"Norway\">Norway<\/option><option value=\"Poland\">Poland<\/option><option value=\"Portugal\">Portugal<\/option><option value=\"Romania\">Romania<\/option><option value=\"Singapore\">Singapore<\/option><option value=\"Slovakia\">Slovakia<\/option><option value=\"Slovenia\">Slovenia<\/option><option value=\"South Korea\">South Korea<\/option><option value=\"Spain\">Spain<\/option><option value=\"Sweden\">Sweden<\/option><option value=\"Switzerland\">Switzerland<\/option><option value=\"Taiwan\">Taiwan<\/option><option value=\"Thailand\">Thailand<\/option><option value=\"Turkey (T\u00fcrkiye)\">Turkey (T\u00fcrkiye)<\/option><option value=\"United Kingdom\">United Kingdom<\/option><option value=\"United States\">United States<\/option><option value=\"Uruguay\">Uruguay<\/option><\/select><\/p><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_kind\">Type studie<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_kind\" name=\"t_kind\"><option value=\"\">Alle studies<\/option><option value=\"INTERVENTIONAL\">Interventioneel (behandeling)<\/option><option value=\"OBSERVATIONAL\">Observationeel (register, beeldvorming)<\/option><\/select><\/p><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_status\">Status<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_status\" name=\"t_status\"><option value=\"\">Alle statussen<\/option><option value=\"RECRUITING\">Werving loopt<\/option><option value=\"NOT_YET_RECRUITING\">Nog niet open<\/option><option value=\"ENROLLING_BY_INVITATION\">Op uitnodiging<\/option><\/select><\/p><p class=\"aa-trial-filters__actions\"><button type=\"submit\" class=\"aa-trial-filters__submit\">Filteren<\/button><a class=\"aa-trial-filters__reset\" href=\"https:\/\/www.amyloidosisalliance.org\/nl\/\" hidden>Filters wissen<\/a><\/p><\/form><div class=\"aa-trial-results\" aria-live=\"polite\" aria-busy=\"false\"><p class=\"aa-trial-count\">1 tot 12 van 203 studies<\/p><div class=\"aa-trial-grid\"><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Werving loopt<\/span><span class=\"aa-trial-type\">Niet vermeld<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07589595\" target=\"_blank\" rel=\"noopener noreferrer\">A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The main purpose of this study is to evaluate whether treatment with donanemab slows the progression of cognitive (how we think, learn, remember, pay\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventioneel (behandeling)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 2<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Eli Lilly and Company<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Werving in: <\/span><span class=\"aa-trial-place\">Japan<\/span><span class=\"aa-trial-place\">South Korea<\/span><span class=\"aa-trial-place\">Taiwan<\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07589595<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 4 november 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Werving loopt<\/span><span class=\"aa-trial-type\">ATTR (transthyretine)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06128629\" target=\"_blank\" rel=\"noopener noreferrer\">MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">To evaluate the efficacy and safety of a single dose of NTLA-2001 compared to placebo in participants with ATTR-CM.<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventioneel (behandeling)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 3<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Intellia Therapeutics<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Werving in: <\/span><span class=\"aa-trial-place\">Argentina<\/span><span class=\"aa-trial-place\">Australia<\/span><span class=\"aa-trial-place\">Austria<\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place aa-trial-place--more\">+22<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT06128629<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 4 november 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Werving loopt<\/span><span class=\"aa-trial-type\">ATTR (transthyretine)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06978660\" target=\"_blank\" rel=\"noopener noreferrer\">Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">CONCERTO is a retrospective, observational, multicentric and single-arm study to perform an external validation of the cloud-based and AI-powered electrocardiogram (ECG) analysis platform, named\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Observationeel (register, beeldvorming)<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Idoven 1903 S.L.<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Werving in: <\/span><span class=\"aa-trial-place\">France<\/span><span class=\"aa-trial-place\">Germany<\/span><span class=\"aa-trial-place\">Spain<\/span><span class=\"aa-trial-place\">United Kingdom<\/span><span class=\"aa-trial-place aa-trial-place--more\">+1<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT06978660<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 4 november 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Werving loopt<\/span><span class=\"aa-trial-type\">AL (lichte ketens)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06971380\" target=\"_blank\" rel=\"noopener noreferrer\">Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">A Phase II study of HBI0101 (NXC-201) BCMA-CART in Multiple Myeloma and Light-chain Amyloidosis Patients. The goal of the study is to evaluate the\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventioneel (behandeling)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 2<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Polina Stepensky<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Werving in: <\/span><span class=\"aa-trial-place\">Israel<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT06971380<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 4 november 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Werving loopt<\/span><span class=\"aa-trial-type\">Niet vermeld<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04776824\" target=\"_blank\" rel=\"noopener noreferrer\">Swiss Cardiac Amyloidosis REgistry (Swiss-CARE)<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">Cardiac transthyretin amyloidosis (ATTR), caused by ventricular depositions of misfolded transthyretin, results in an infiltrative cardiomyopathy, progressing from pronounced myocardial wall thickening, diastolic and\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Observationeel (register, beeldvorming)<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Insel Gruppe AG, University Hospital Bern<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Werving in: <\/span><span class=\"aa-trial-place\">Switzerland<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT04776824<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 4 november 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Werving loopt<\/span><span class=\"aa-trial-type\">AL (lichte ketens)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05652335\" target=\"_blank\" rel=\"noopener noreferrer\">A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The primary purpose of this study is to identify the recommended phase 2 dose (RP2D[s]) and schedule(s) to be safe for JNJ-79635322 in Part\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventioneel (behandeling)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 1<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Janssen Research &amp; Development, LLC<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Werving in: <\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place\">France<\/span><span class=\"aa-trial-place\">Japan<\/span><span class=\"aa-trial-place\">Netherlands<\/span><span class=\"aa-trial-place aa-trial-place--more\">+3<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT05652335<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 3 november 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Werving loopt<\/span><span class=\"aa-trial-type\">AL (lichte ketens)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07224672\" target=\"_blank\" rel=\"noopener noreferrer\">A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The study aims to evaluate the efficacy and safety of belantamab mafodotin in combination with cyclophosphamide, bortezomib, and dexamethasone in adult participants with newly\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventioneel (behandeling)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 2<\/dd><\/div><div><dt>Sponsor<\/dt><dd>GlaxoSmithKline<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Werving in: <\/span><span class=\"aa-trial-place\">Australia<\/span><span class=\"aa-trial-place\">United Kingdom<\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07224672<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 3 november 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--not-yet-recruiting\">Nog niet open<\/span><span class=\"aa-trial-type\">ATTR (transthyretine)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05974644\" target=\"_blank\" rel=\"noopener noreferrer\">Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The study design is a prospective registry including asymptomatic and symptomatic patients who carry a pathogenic TTR mutation. The study will enroll patients who\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Observationeel (register, beeldvorming)<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Virginia Commonwealth University<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Werving in: <\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT05974644<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 3 november 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Werving loopt<\/span><span class=\"aa-trial-type\">ATTR (transthyretine)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06845644\" target=\"_blank\" rel=\"noopener noreferrer\">Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The pathophysiological process common to neuropathies is fatty replacement of muscle tissue, more commonly known as intramuscular fat fraction (F.F). MRI is an imaging\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventioneel (behandeling)<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Assistance Publique Hopitaux De Marseille<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Werving in: <\/span><span class=\"aa-trial-place\">France<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT06845644<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 29 oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--not-yet-recruiting\">Nog niet open<\/span><span class=\"aa-trial-type\">ATTR (transthyretine)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07591038\" target=\"_blank\" rel=\"noopener noreferrer\">PET\/CT Imaging in Carriers of TTR Mutations<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The purpose of this study is to determine if TTR gene carriers have early signs of a type of heart disease called amyloidosis using\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Observationeel (register, beeldvorming)<\/dd><\/div><div><dt>Sponsor<\/dt><dd>University of Texas Southwestern Medical Center<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Werving in: <\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07591038<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 29 oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--not-yet-recruiting\">Nog niet open<\/span><span class=\"aa-trial-type\">AL (lichte ketens)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07901725\" target=\"_blank\" rel=\"noopener noreferrer\">Linvoseltamab Versus Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone (Dara-Vcd) in Adult Participants With Newly Diagnosed Systemic Light Chain Amyloidosis<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">This study is researching a Regeneron drug called linvoseltamab (&quot;study drug&quot;) alone compared to standard of care (SoC) combination to see if it can\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventioneel (behandeling)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 3<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Regeneron Pharmaceuticals<\/dd><\/div><\/dl><p class=\"aa-trial-card__places aa-trial-card__places--none\">Nog geen studielocaties vermeld<\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07901725<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 28 oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--not-yet-recruiting\">Nog niet open<\/span><span class=\"aa-trial-type\">AL (lichte ketens)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07615270\" target=\"_blank\" rel=\"noopener noreferrer\">A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement<span class=\"screen-reader-text\"> (opent op ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">This is an exploratory study to assess the binding of CAEL-101\/anselamimab to amyloid in vivo, recruitment of inflammatory cells and reduction of the amyloid\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventioneel (behandeling)<\/dd><\/div><div><dt>Fase<\/dt><dd>Vroege fase 1<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Stanford University<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Werving in: <\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07615270<\/span><span class=\"aa-trial-card__updated\">Bijgewerkt op 27 oktober 2026<\/span><\/p><\/article><\/div><nav class=\"aa-trial-pager\" aria-label=\"Pagina\u2019s van de studielijst\"><span aria-current=\"page\" class=\"page-numbers current\">1<\/span><a class=\"page-numbers\" href=\"https:\/\/www.amyloidosisalliance.org\/nl\/?t_page=2\">2<\/a><span class=\"page-numbers dots\">&hellip;<\/span><a class=\"page-numbers\" href=\"https:\/\/www.amyloidosisalliance.org\/nl\/?t_page=17\">17<\/a><a class=\"next page-numbers\" href=\"https:\/\/www.amyloidosisalliance.org\/nl\/?t_page=2\">Volgende<\/a><\/nav><div class=\"aa-trial-registry\"><p class=\"aa-trial-registry__text\">Deze lijst bevat alleen studies naar amylo\u00efdose die open zijn of binnenkort opengaan. Het register bevat alle studies, ook de studies die al zijn afgerond.<\/p><div class=\"wp-block-button aa-btn aa-btn--teal\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">Alle studies zoeken op ClinicalTrials.gov<span class=\"screen-reader-text\"> (opent in een nieuw tabblad)<\/span><\/a><\/div><\/div><p class=\"aa-trial-source\">Bron: ClinicalTrials.gov (U.S. National Library of Medicine). Lijst voor het laatst opgehaald op 4 november 2026. <a href=\"https:\/\/clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">clinicaltrials.gov<\/a><\/p><\/div><\/div><\/div>\n<\/section>\n\n<section class=\"wp-block-group aa-section aa-section--forest aa-cta is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner aa-narrow aa-text-center is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading\">Weet u niet waar u moet beginnen?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Onze lidorganisaties kennen de teams die deze studies in hun land uitvoeren en kunnen u helpen het gesprek met uw arts voor te bereiden.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-aec23bef wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button aa-btn aa-btn--primary\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.amyloidosisalliance.org\/nl\/leden\/\">Zoek een vereniging bij u in de buurt<\/a><\/div>\n\n\n\n<div class=\"wp-block-button aa-btn aa-btn--ghost-paper\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.amyloidosisalliance.org\/nl\/neem-contact-met-ons-op\/\">Neem contact op met de Alliantie<\/a><\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Home\u203aKlinische studies Onderzoek Klinische studies Alle studies naar amylo\u00efdose die nu pati\u00ebnten werven, binnenkort starten of op uitnodiging deelnemers opnemen, waar ook ter wereld, rechtstreeks overgenomen van ClinicalTrials.gov en elke dag bijgewerkt. Informatie, geen medisch advies. De Alliantie voert deze studies niet uit en kan u er niet voor inschrijven. Lijkt een studie u relevant, [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3617","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Klinische studies naar amylo\u00efdose die wereldwijd pati\u00ebnten werven<\/title>\n<meta name=\"description\" content=\"Alle studies naar amylo\u00efdose die nu pati\u00ebnten werven of binnenkort starten, overgenomen van ClinicalTrials.gov en dagelijks bijgewerkt. Filter op soort, land en status.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Klinische studies naar amylo\u00efdose die wereldwijd pati\u00ebnten werven\" \/>\n<meta property=\"og:description\" content=\"Alle studies naar amylo\u00efdose die nu pati\u00ebnten werven of binnenkort starten, overgenomen van ClinicalTrials.gov en dagelijks bijgewerkt. Filter op soort, land en status.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/\" \/>\n<meta property=\"og:site_name\" content=\"Amyloidosis Alliance\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AmyloidosisAlliance\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-03T07:38:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1707\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@amyloidosisa\" \/>\n<meta name=\"twitter:label1\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/klinische-studies\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/klinische-studies\\\/\",\"name\":\"Klinische studies naar amylo\u00efdose die wereldwijd pati\u00ebnten werven\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/klinische-studies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/klinische-studies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\",\"datePublished\":\"2026-09-07T14:16:46+00:00\",\"dateModified\":\"2026-11-03T07:38:44+00:00\",\"description\":\"Alle studies naar amylo\u00efdose die nu pati\u00ebnten werven of binnenkort starten, overgenomen van ClinicalTrials.gov en dagelijks bijgewerkt. Filter op soort, land en status.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/klinische-studies\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/klinische-studies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/klinische-studies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/klinische-studies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Klinische studies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/\",\"name\":\"Amyloidosis Alliance\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#organization\",\"name\":\"Amyloidosis Alliance\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"width\":252,\"height\":252,\"caption\":\"Amyloidosis Alliance\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AmyloidosisAlliance\\\/\",\"https:\\\/\\\/x.com\\\/amyloidosisa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Klinische studies naar amylo\u00efdose die wereldwijd pati\u00ebnten werven","description":"Alle studies naar amylo\u00efdose die nu pati\u00ebnten werven of binnenkort starten, overgenomen van ClinicalTrials.gov en dagelijks bijgewerkt. Filter op soort, land en status.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/","og_locale":"nl_NL","og_type":"article","og_title":"Klinische studies naar amylo\u00efdose die wereldwijd pati\u00ebnten werven","og_description":"Alle studies naar amylo\u00efdose die nu pati\u00ebnten werven of binnenkort starten, overgenomen van ClinicalTrials.gov en dagelijks bijgewerkt. Filter op soort, land en status.","og_url":"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/","og_site_name":"Amyloidosis Alliance","article_publisher":"https:\/\/www.facebook.com\/AmyloidosisAlliance\/","article_modified_time":"2026-11-03T07:38:44+00:00","og_image":[{"width":1707,"height":1707,"url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@amyloidosisa","twitter_misc":{"Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/","url":"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/","name":"Klinische studies naar amylo\u00efdose die wereldwijd pati\u00ebnten werven","isPartOf":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/#primaryimage"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg","datePublished":"2026-09-07T14:16:46+00:00","dateModified":"2026-11-03T07:38:44+00:00","description":"Alle studies naar amylo\u00efdose die nu pati\u00ebnten werven of binnenkort starten, overgenomen van ClinicalTrials.gov en dagelijks bijgewerkt. Filter op soort, land en status.","breadcrumb":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/#primaryimage","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/klinische-studies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.amyloidosisalliance.org\/nl\/home\/"},{"@type":"ListItem","position":2,"name":"Klinische studies"}]},{"@type":"WebSite","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#website","url":"https:\/\/www.amyloidosisalliance.org\/nl\/","name":"Amyloidosis Alliance","description":"","publisher":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.amyloidosisalliance.org\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#organization","name":"Amyloidosis Alliance","url":"https:\/\/www.amyloidosisalliance.org\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","width":252,"height":252,"caption":"Amyloidosis Alliance"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AmyloidosisAlliance\/","https:\/\/x.com\/amyloidosisa"]}]}},"_links":{"self":[{"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/pages\/3617","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/comments?post=3617"}],"version-history":[{"count":1,"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/pages\/3617\/revisions"}],"predecessor-version":[{"id":3618,"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/pages\/3617\/revisions\/3618"}],"wp:attachment":[{"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/media?parent=3617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}